MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance [exome-seq]
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP388035
下载链接
链接失效反馈官方服务：
资源简介：
Pre-clinical model to study tumor immune resistance are essential. To this end, we generated cell lines from tumors induced on BrafV600E Pten-/- mice. The cell lines have been characterized to evaluate the tumor growth in vivo and response to immunotherapies. In addition, we have also chaacterised the DNA expression profile of the cell lines. Overall design: Cell lines were left untreated and harvested for DNA sequencing analysis.
创建时间：
2023-07-30
